Maxime Meloche1,2, Hyuk J Kwon1, Nathalie Letarte1,3, Jean-François Bussières1,4, Barbara Vadnais1,5, Thierry Hurlimann6, Annie Lavoie4, Marie-France Beauchesne1,7, Simon de Denus1,2. 1. Faculty of Pharmacy, Université de Montréal, Montreal, Canada. 2. Montreal Heart Institute, Montreal, Canada. 3. Department of Pharmacy, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. 4. Department of Pharmacy, Sainte-Justine University Hospital Center, Montreal, Canada. 5. Department of Pharmacy, Hôpital Maisonneuve-Rosemont, Montreal, Canada. 6. Department of Social & Preventive Medicine, Bioethics Programs, Faculty of Medicine, Université de Montréal, Montreal, Canada. 7. Research Center, Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie-Centre Hospitalier Universitaire de Sherbrooke, Installations Hôtel-Dieu et Fleurimont, Sherbrooke, Canada.
Abstract
Aim: To evaluate the current opinion, experience and educational preferences of pharmacists in Quebec concerning pharmacogenomics. Method: A web-based survey containing 25 questions was sent to all Quebec pharmacists. Results: Most pharmacists were willing to advise patients (81%) and physicians (84%) on treatment choices based on pharmacogenomic test results after proper training. Only 31% had been previously exposed to pharmacogenomic test results, and 91% were favorable to pharmacogenomics training, with e-learning through interactive video sessions (69%). The preferred training session length was between 1 and 3 h (59%). Hospital pharmacists were more often exposed to pharmacogenomic tests (p < 0.0001) and more frequently advised patients on treatment choices (p < 0.001) than community pharmacists. Conclusion: Pharmacists remain favorable toward pharmacogenomics, but its use in clinical practice stays limited. Identifying the educational preferences of pharmacists may help in the development of educational programs to help them integrate pharmacogenomics in their clinical practice.
Aim: To evaluate the current opinion, experience and educational preferences of pharmacists in Quebec concerning pharmacogenomics. Method: A web-based survey containing 25 questions was sent to all Quebec pharmacists. Results: Most pharmacists were willing to advise patients (81%) and physicians (84%) on treatment choices based on pharmacogenomic test results after proper training. Only 31% had been previously exposed to pharmacogenomic test results, and 91% were favorable to pharmacogenomics training, with e-learning through interactive video sessions (69%). The preferred training session length was between 1 and 3 h (59%). Hospital pharmacists were more often exposed to pharmacogenomic tests (p < 0.0001) and more frequently advised patients on treatment choices (p < 0.001) than community pharmacists. Conclusion: Pharmacists remain favorable toward pharmacogenomics, but its use in clinical practice stays limited. Identifying the educational preferences of pharmacists may help in the development of educational programs to help them integrate pharmacogenomics in their clinical practice.
Authors: Mathushan Subasri; David Barrett; Jovana Sibalija; Lisa Bitacola; Richard B Kim Journal: Clin Transl Sci Date: 2021-07-16 Impact factor: 4.689